Enhanced expression of a tumor‐cell‐derived collagenase‐stimulatory factor in urothelial carcinoma: Its usefulness as a tumor marker for bladder cancers
- 19 August 1993
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 55 (1), 19-26
- https://doi.org/10.1002/ijc.2910550105
Abstract
A mouse monoclonal antibody (MAb) E11F4, previously raised against the tumor-cell-derived collagenase-stimulatory factor (TCSF) from LX-1 human lung-carcinoma cells, has been used to define the expression and distribution of TCSF in human non-neoplastic urothelium and tumors of the urinary bladder. Immunohistochemically, TCSF was detected in 27/28 transitional-cell carcinomas (TCC) of the bladder, of which 23 were judged to be positive for TCSF according to objective criteria. Twenty-four of 28 non-neoplastic urothelium from 22 individuals were judged to be negative for TCSF by this criteria. However, TCSF immunostaining that was confined to the superficial umbrella cells was frequently observed in nonneoplastic urothelium. In bladder carcinomas, TCSF was in most cases demonstrated in the majority of cells, including at the invasion front. Its localization to the cell membrane was demonstrated by immunoelectron microscopy. The high level of expression of TCSF in bladder tumors, but not in non-neoplastic urothelium, was also demonstrated by immunoblotting of tissue extracts. Furthermore, E11F4 immunostaining identified tumor cells obtained from bladder washings or voided urine and detected more TCC cases than conventional cytology. Since TCSF immunostaining was positive even in low-grade TCC (immunohistochemically and immunocytochemically in 4/5 TCC grade I), the application of TCSF immunostaining to urine cytology appears promising as a valuable adjunct to conventional methods in the clinical evaluation of patients with TCC.Keywords
This publication has 17 references indexed in Scilit:
- Monoclonal antibody against a tumor‐associated sialoglycoprotein of superficial papillary bladder tumors and cervical condylomasInternational Journal of Cancer, 1990
- A New Method for Evaluation of Urinary Autocrine Motility Factor and Tumor Cell Collagenase Stimulating Factor as Markers for Urinary Tract CancersJournal of Occupational and Environmental Medicine, 1990
- Membrane association of collagenase stimulatory factor(s) from B‐16 melanoma cellsJournal of Cellular Biochemistry, 1987
- Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.Proceedings of the National Academy of Sciences, 1987
- Immunopathology of urothelial lesions: immunological markers as predictive for clinical aggressivenessWorld Journal of Urology, 1987
- Monoclonal Antibody 486 P 3/12: A Valuable Bladder Carcinoma Marker for ImmunocytologyJournal of Urology, 1987
- Collagenase stimulation in cocultures of human fibroblasts and human tumor cellsCancer Letters, 1984
- Estimation of changes in bladder cancer mortality and prevalence of diagnosed casesUrology, 1984
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigenInternational Journal of Cancer, 1973